252 related articles for article (PubMed ID: 32710679)
21. TIPS for management of refractory ascites: response and survival are both unpredictable.
Thuluvath PJ; Bal JS; Mitchell S; Lund G; Venbrux A
Dig Dis Sci; 2003 Mar; 48(3):542-50. PubMed ID: 12757168
[TBL] [Abstract][Full Text] [Related]
22. Effect of splenectomy on the outcomes in patients with cirrhosis receiving transjugular intrahepatic portosystemic shunt.
Yang C; Liu J; Shi Q; Huang S; Zhou C; Wang Y; Li T; Chen Y; Xiong B
J Gastroenterol Hepatol; 2021 Oct; 36(10):2893-2902. PubMed ID: 33973270
[TBL] [Abstract][Full Text] [Related]
23. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
24. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
[TBL] [Abstract][Full Text] [Related]
25. Thirty-Day Readmission Among Patients With Non-Variceal Upper Gastrointestinal Hemorrhage and Effects on Outcomes.
Abougergi MS; Peluso H; Saltzman JR
Gastroenterology; 2018 Jul; 155(1):38-46.e1. PubMed ID: 29601829
[TBL] [Abstract][Full Text] [Related]
26. High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt Creation.
Kloster ML; Ren A; Shah KY; Alqadi MM; Bui JT; Lipnik AJ; Niemeyer MM; Ray CE; Gaba RC
Dig Dis Sci; 2021 Nov; 66(11):4058-4062. PubMed ID: 33236314
[TBL] [Abstract][Full Text] [Related]
27. Hospital readmissions among patients with decompensated cirrhosis.
Volk ML; Tocco RS; Bazick J; Rakoski MO; Lok AS
Am J Gastroenterol; 2012 Feb; 107(2):247-52. PubMed ID: 21931378
[TBL] [Abstract][Full Text] [Related]
28. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.
Bureau C; Thabut D; Oberti F; Dharancy S; Carbonell N; Bouvier A; Mathurin P; Otal P; Cabarrou P; Péron JM; Vinel JP
Gastroenterology; 2017 Jan; 152(1):157-163. PubMed ID: 27663604
[TBL] [Abstract][Full Text] [Related]
29. Advanced chronic renal disease is an independent risk factor for inpatient mortality following transjugular intrahepatic portosystemic shunt procedure.
Li R; Sarin S
Eur J Gastroenterol Hepatol; 2024 Mar; 36(3):332-337. PubMed ID: 38179873
[TBL] [Abstract][Full Text] [Related]
30. Transjugular intrahepatic portosystemic shunt in refractory hydrothorax - a contribution to an unexplored indication.
Campos S; Gomes D; Sofia C
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):661-6. PubMed ID: 27002676
[TBL] [Abstract][Full Text] [Related]
31. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
[TBL] [Abstract][Full Text] [Related]
32. Which Clinical and Patient Factors Influence the National Economic Burden of Hospital Readmissions After Total Joint Arthroplasty?
Kurtz SM; Lau EC; Ong KL; Adler EM; Kolisek FR; Manley MT
Clin Orthop Relat Res; 2017 Dec; 475(12):2926-2937. PubMed ID: 28108823
[TBL] [Abstract][Full Text] [Related]
33. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
[TBL] [Abstract][Full Text] [Related]
34. [Follow-up study of 116 cases of transjugular intrahepatic portosystemic shunt in the treatment of cirrhotic portal hypertension].
Liu MH; Zhou F; Wang XB; Chen LP; Li GZ; Zhao Q
Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):596-600. PubMed ID: 30317791
[No Abstract] [Full Text] [Related]
35. Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation.
Zuo L; Lv Y; Wang Q; Yin Z; Wang Z; He C; Guo W; Niu J; Bai W; Li K; Yu T; Yuan X; Chen H; Liu H; Xia D; Wang E; Luo B; Li X; Yuan J; Han N; Nie Y; Fan D; Han G
J Vasc Interv Radiol; 2019 Feb; 30(2):148-153.e2. PubMed ID: 30638778
[TBL] [Abstract][Full Text] [Related]
36. Hospital volume and mortality after transjugular intrahepatic portosystemic shunt creation in the United States.
Sarwar A; Zhou L; Novack V; Tapper EB; Curry M; Malik R; Ahmed M
Hepatology; 2018 Feb; 67(2):690-699. PubMed ID: 28681542
[TBL] [Abstract][Full Text] [Related]
37. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ
Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
[TBL] [Abstract][Full Text] [Related]
38. Transjugular intrahepatic portosystemic shunt reduces hospital care burden in patients with decompensated cirrhosis.
Ballester MP; Lluch P; Gómez C; Capilla M; Tosca J; Martí-Aguado D; Guijarro J; Mínguez M
Intern Emerg Med; 2021 Sep; 16(6):1519-1527. PubMed ID: 33400160
[TBL] [Abstract][Full Text] [Related]
39. Impact of sleep apnoea on 30 day hospital readmission rate and cost in heart failure with reduced ejection fraction.
Mathew D; Kosuru B; Agarwal S; Shrestha U; Sherif A
ESC Heart Fail; 2023 Aug; 10(4):2534-2540. PubMed ID: 37295960
[TBL] [Abstract][Full Text] [Related]
40. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
Lin ZP; Chen SL; Wang JY; Liu F; Tan Q; Peng QF; Zhao JB
Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):672-678. PubMed ID: 32911906
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
